Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.
Authors: Moore LE,  Jaeger E,  Nickerson ML,  Brennan P,  De Vries S,  Roy R,  Toro J,  Li H,  Karami S,  Lenz P,  Zaridze D,  Janout V,  Bencko V,  Navratilova M,  Szeszenia-Dabrowska N,  Mates D,  Linehan WM,  Merino M,  Simko J,  Pfeiffer R,  Boffetta P,  Hewitt S,  Rothman N,  Chow WH,  Waldman FM
Journal: Oncogenesis
Date: 2012 Jun 25
Branches: BB, ITEB, LTG, OEEB
PubMed ID: 23552698
PMC ID: PMC3412648
Abstract: Array comparative genomic hybridization was used to identify copy number alterations in clear cell renal cell carcinoma (ccRCC) patient tumors to identify associations with patient/clinical characteristics. Of 763 ccRCC patients, 412 (54%) provided frozen biopsies. Clones were analyzed for significant copy number differences, adjusting for multiple comparisons and covariates in multivariate analyses. Frequent alterations included losses on: 3p (92.2%), 14q (46.8%), 8p (38.1%), 4q (35.4%), 9p (32.3%), 9q (31.8%), 6q (30.8%), 3q (29.4%), 10q (25.7%), 13q (24.5%), 1p (23.5%) and gains on 5q (60.2%), 7q (39.6%), 7p (30.6%), 5p (26.5%), 20q (25.5%), 12q (24.8%), 12p (22.8%). Stage and grade were associated with 1p, 9p, 9q, 13q and 14q loss and 12q gain. Males had more alterations compared with females, independent of stage and grade. Significant differences in the number/types of alterations were observed by family cancer history, age at diagnosis and smoking status. Von Hippel-Lindau (VHL) gene inactivation was associated with 3p loss (P